FDA Drug Recalls

Recalls / Class II

Class IID-0507-2021

Product

NOHIST-DM Antihistamine/Antitussive Nasal Decongestant 16 fl. oz. (473 mL) NDC 68047-186-16 Distributed by: Larken Laboratories, Inc. Canton, MS 39046

Brand name
Nohist Dm
Generic name
Chlorpheniramine Maleate, Dextromethorphan Hydrobromide And Phenylephrine Hydrochloride
Active ingredients
Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Route
Oral
NDC
68047-186
FDA application
M012
Affected lot / code info
All Lots distributed 02/23/2021 through 03/10/2021.

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recalling firm

Firm
Cardinal Health Inc.
Manufacturer
Larken Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091

Distribution

Quantity
24 bottles
Distribution pattern
FL, GA, SC

Timeline

Recall initiated
2021-03-15
FDA classified
2021-05-24
Posted by FDA
2021-06-02
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0507-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.